CN1299663A - Diabetes treating medicine - Google Patents

Diabetes treating medicine Download PDF

Info

Publication number
CN1299663A
CN1299663A CN00136252A CN00136252A CN1299663A CN 1299663 A CN1299663 A CN 1299663A CN 00136252 A CN00136252 A CN 00136252A CN 00136252 A CN00136252 A CN 00136252A CN 1299663 A CN1299663 A CN 1299663A
Authority
CN
China
Prior art keywords
radix
herba
fructus
medicine
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN00136252A
Other languages
Chinese (zh)
Other versions
CN1101213C (en
Inventor
朱保霖
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN00136252A priority Critical patent/CN1101213C/en
Publication of CN1299663A publication Critical patent/CN1299663A/en
Application granted granted Critical
Publication of CN1101213C publication Critical patent/CN1101213C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Abstract

The Chinese patent medicine for curing diabetes is made up by 16 Chinese medicinal materials of astragalus root, ginseng, tortoise plastron, epimedium, dipsacus root, mistletoe, Chinese yam and others. Said medicine possesses the functions of supplementing center, boosting qi, enriching yin, engendering liquid, promoting blood circulation, removing stasis and supplementing kidney-yang, so that it can obtain good therapeutic effect.

Description

A kind of medicine for the treatment of diabetes
The present invention relates to a kind of medicine for the treatment of diabetes, is the Chinese patent medicine that is used for the treatment of diabetes specifically.
Diabetes are commonly encountered diseases and the frequently-occurring diseases in the present worldwide, and sickness rate has the gesture of rising year by year, still do not have the radical cure method so far.Diabetic causes sugar because insulin deficit, fatty and proteinic metabolism disorder, and blood sugar increasing, blood viscosity increases, and prolonged illness then causes the extensive microangiopathies of whole body, thereby on the optical fundus, positions such as cardiovascular and cerebrovascular vessel, kidney cause severe complication.
There are some defectives in doctor trained in Western medicine on the treatment diabetes at present.Biguanides, sulfonylureas drugs for diabetes side effect are big, infringement liver, kidney etc.; With producing antibody, curative effect descends insulin for a long time, and dosage is difficult for grasping simultaneously, may cause hypoglycemia, and insulin injection also can bring pain to the patient.Though the Chinese medicine of treatment diabetes is a lot of, person evident in efficacy is rarely seen.
Therefore, the purpose of this invention is to provide a kind of effective blood sugar lowering, microcirculation improvement, the medicine of the treatment diabetes of activation pancreatic functions.
Diabetes are doctor trained in Western medicine names of disease, belong to the category of diabete in the traditional Chinese medical science.Treated the pathogeny of many, the blood stagnancy due to deficiency of QI scorching of the Chinese medicine of diabetes in the past, taked nourishing YIN and clearing away heat, the method prescription of activating blood circulation to dissipate blood stasis based on the deficiency of YIN.Solution of the present invention is based on the understanding of motherland's Chinese medicine to diabetes and complication mechanism thereof, and through the studying intensively with great concentration of present inventor, new development is arranged on its basis.The present inventor finds that diabetes initial stage many genus deficiency of YIN is scorching, and the prolonged illness yang-energy is also empty, only takes the method for yin yang complementarity, just can receive good effect, reaches the radical cure purpose.Therefore medicine of the present invention has adopted tonifying QI to produce body fluid, yin yang complementarity, and the method for activating blood circulation to dissipate blood stasis, and based on this selected medicament composing prescription.Medicine of the present invention nourishes internal organs by skin care, recovers function, thereby activates the pancreas endocrine function, makes blood glucose slowly recover normal.
Medicine of the present invention is made by following component: (consumption is a weight portion)
Radix Astragali 8-15 Radix Ginseng 15-25 Carapax et Plastrum Testudinis 8-15
Herba Epimedii 8-15 Radix Dipsaci 10-30 Herba Taxilli 10-30
Rhizoma Dioscoreae 15-30 Flos Carthami 8-15 Olibanum 8-15
Myrrha 8-15 Fructus Rubi 15-30 Cortex Eucommiae 15-30
Radix Puerariae 15-30 Herba Dendrobii 15-25 Fructus Corni 15-25
Fructus Lycii 25-35
The best proportioning of aforementioned pharmaceutical compositions is:
The Radix Astragali 10 Radix Ginsengs 20 Carapax et Plastrum Testudiniss 10
Herba Epimedii 10 Radix Dipsacis 15 Herba Taxillis 15
Rhizoma Dioscoreae 20 Flos Carthamis 10 Olibanums 10
Myrrha 10 Fructus Rubies 20 Cortexs Eucommiae 20
Radix Puerariae 20 Herba Dendrobiis 20 Fructus Corni 20
Fructus Lycii 30
Aforementioned pharmaceutical compositions of the present invention is to form according to the theory of Chinese medical science prescription.The Radix Astragali wherein, Radix Ginseng, Rhizoma Dioscoreae invigorating the spleen and replenishing QI, Carapax et Plastrum Testudinis, Herba Taxilli, Fructus Corni, Fructus Rubi, Fructus Lycii, the moon of Herba Dendrobii tonifying the lung stomach kidney, Flos Carthami, Olibanum, Myrrha activating blood circulation to dissipate blood stasis, Herba Epimedii, Radix Dipsaci, Cortex Eucommiae kidney-replenishing, Radix Puerariae clearing away heat and promoting production of body fluid.According to the pharmaceutical technology of routine, aforementioned pharmaceutical compositions can be prepared into any pharmaceutical dosage form that is suitable for using clinically, as pill, powder, capsule, tablet, oral liquid etc.
The method that aforementioned pharmaceutical compositions is prepared into pill is: disposable powder is broken into powder, crosses 100 mesh sieves, becomes pill with processed with honey again.
Pharmaceutical preparation of the present invention is used for clinical practice, has obtained notable therapeutic effect.The characteristics of medicine of the present invention are not avoid sweet food during the treatment, though that blood glucose descends is comparatively slow, can effect a radical cure.The Therapeutic Method of medicine of the present invention is the pill administration of adopting pharmaceutical composition of the present invention to make, and 15 days is a course of treatment, be interrupted later on and keep treatment general continuous four, five courses of treatment, up to the blood glucose long-term stability at normal level.Through selecting treatment 120 routine patients, 110 examples are person in middle and old age's type patient, and all the other 10 examples are type.II type patient's clinical symptoms such as three-many-one-little etc. 100% are alleviated after one course of treatment, and I type patient also all alleviates.Through keeping the treatment 4-5 course of treatment, II type patient 80% blood glucose is reduced to below the 130mg/L, all the other 20% declines that also have in various degree.
Embodiment 1
Radix Astragali 10g Radix Ginseng 20g Carapax et Plastrum Testudinis 10g
Herba Epimedii 10g Radix Dipsaci 15g Herba Taxilli 15g
Rhizoma Dioscoreae 20g Flos Carthami 10g Olibanum 10g
Myrrha 10g Fructus Rubi 20g Cortex Eucommiae 20g
Radix Puerariae 20g Herba Dendrobii 20g Fructus Corni 20g
Fructus Lycii 30g
With said medicine oven dry, be ground into fine powder, cross 100 mesh sieves, again and honey, make pill, every ball 8 grams, or medicated powder incapsulated, every capsules contains medicated powder 1 gram.
Embodiment 2
Radix Astragali 15g Radix Ginseng 25g Carapax et Plastrum Testudinis 15g
Herba Epimedii 15g Radix Dipsaci 20g Herba Taxilli 20g
Rhizoma Dioscoreae 25g Flos Carthami 12g Olibanum 12g
Myrrha 12g Fructus Rubi 25g Cortex Eucommiae 25g
Radix Puerariae 25g Herba Dendrobii 25g Fructus Corni 25g
Fructus Lycii 35g
Method for making is the same.
Embodiment 3
Radix Astragali 8g Radix Ginseng 10g Carapax et Plastrum Testudinis 8g
Herba Epimedii 8g Radix Dipsaci 10g Herba Taxilli 10g
Rhizoma Dioscoreae 15g Flos Carthami 8g Olibanum 8g
Myrrha 8g Fructus Rubi 15g Cortex Eucommiae 15g
Radix Puerariae 15g Herba Dendrobii 15g Fructus Corni 15g
Fructus Lycii 20g
Method for making such as embodiment 1.
Model case
Quiet refined rosy clouds, the woman, 42 years old, Inner Mongol Dong Wu pearl Mu Qin bannerman, the anxious property diabetes of sending out, there is dizziness stadium a year and a half, thirsty drink, eye xerophthalmia flower, the sugared 9.8mmol/L that has a blood test, through treating 5 courses of treatment, blood glucose is reduced to 5.5-6.0mmol/L, and further consultation blood glucose is 5.8mmol/L after half a year.

Claims (4)

1, a kind of pharmaceutical composition for the treatment of diabetes is characterized in that it is the medicament of being made by following raw materials in weight portion:
Radix Astragali 8-15 Radix Ginseng 15-25 Carapax et Plastrum Testudinis 8-15
Herba Epimedii 8-15 Radix Dipsaci 10-30 Herba Taxilli 10-30
Rhizoma Dioscoreae 15-30 Flos Carthami 8-15 Olibanum 8-15
Myrrha 8-15 Fructus Rubi 15-30 Cortex Eucommiae 15-30
Radix Puerariae 15-30 Herba Dendrobii 15-25 Fructus Corni 15-25
Fructus Lycii 25-35
2,, it is characterized in that the weight portion proportioning of each component according to the pharmaceutical composition of claim 1:
The Radix Astragali 10 Radix Ginsengs 20 Carapax et Plastrum Testudiniss 10
Herba Epimedii 10 Radix Dipsacis 15 Herba Taxillis 15
Rhizoma Dioscoreae 20 Flos Carthamis 10 Olibanums 10
Myrrha 10 Fructus Rubies 20 Cortexs Eucommiae 20
Radix Puerariae 20 Herba Dendrobiis 20 Fructus Corni 20
Fructus Lycii 30
3, according to the pharmaceutical composition of claim 1, it is characterized in that: the dosage form of this medicine is a said dosage form on any pharmaceutics.
4, according to the pharmaceutical composition of claim 1, it is characterized in that: the dosage form of this medicine is a pill.
CN00136252A 2000-12-26 2000-12-26 Diabetes treating medicine Expired - Fee Related CN1101213C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN00136252A CN1101213C (en) 2000-12-26 2000-12-26 Diabetes treating medicine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN00136252A CN1101213C (en) 2000-12-26 2000-12-26 Diabetes treating medicine

Publications (2)

Publication Number Publication Date
CN1299663A true CN1299663A (en) 2001-06-20
CN1101213C CN1101213C (en) 2003-02-12

Family

ID=4597170

Family Applications (1)

Application Number Title Priority Date Filing Date
CN00136252A Expired - Fee Related CN1101213C (en) 2000-12-26 2000-12-26 Diabetes treating medicine

Country Status (1)

Country Link
CN (1) CN1101213C (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105709029A (en) * 2014-12-05 2016-06-29 邓世碧 Chinese herbal medicine nutritional agent
CN116870102A (en) * 2023-07-27 2023-10-13 北京力晟鸿吉信息科技发展有限公司 Traditional Chinese medicine composition for reducing blood sugar and application thereof

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105709029A (en) * 2014-12-05 2016-06-29 邓世碧 Chinese herbal medicine nutritional agent
CN116870102A (en) * 2023-07-27 2023-10-13 北京力晟鸿吉信息科技发展有限公司 Traditional Chinese medicine composition for reducing blood sugar and application thereof

Also Published As

Publication number Publication date
CN1101213C (en) 2003-02-12

Similar Documents

Publication Publication Date Title
CN1122522C (en) Medicine 'Yishenjieyu' for treating mental diseases (psychosis)
CN1628840A (en) Medicine for promoting ovulation and aiding pregnancy
CN1513483A (en) Oral liquid for tonifying-kidney and qi contg. eighteen herb medicines, and prepn. method thereof
CN1108804C (en) Diabetes treating medicine and its prepn. method
CN1814208A (en) Oral Chinese medicine for treating and preventing recurrence of uecerative stomatitis
CN1052164C (en) Chinese medicinal preparation for senile dementia
CN1101213C (en) Diabetes treating medicine
CN1403103A (en) Arthralgia pain treating bolus and its prepn
CN1745775A (en) Medicine with kidney warming and Yang tonifying functions and its preparation thereof
CN1066332C (en) Hypoglycemic compound capsule
CN102114185B (en) Medicament for treating insulin resistance of type 2 diabetes
CN1108159C (en) Traditional Chinese medicine for curing diabetes and kidney deficiency
CN1053111C (en) Chinese medical composite preparation with such functions as dispelling toxicity, detoxicating, recuperating, health preserving and face nursing
CN1052419C (en) Herb medicine for treating diabetes mellitus
CN1169564C (en) New medicine for curing diobetes
CN1111426C (en) Diabetes treating medicine
CN1186036C (en) Diabetes treating medicine and its prepn
CN1272054C (en) Medicine for treating diabetes and its preparing process
CN1883593A (en) Blood-nourishing oral liquid with nine ingredients
CN1294983C (en) Medicine for treating facial paralysis and its preparing method
CN1054524C (en) Medicinal composition for treating diabetes involving upper jiao
CN1365828A (en) Medicine for treating diabetes
CN1864728A (en) Prescription and preparation method of yin-nourishing capsule containing ginseng and astragalus root
CN1054525C (en) Medicinal composition for treating diabetes involving lower jiao
CN1259956C (en) Chinese medicine composition for treating heart, kidney and multiple-organ failure and its prepn

Legal Events

Date Code Title Description
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C06 Publication
PB01 Publication
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee